Investec Bank plc has filed a Form 8.5 regulatory disclosure revealing significant share dealings in Advanced Medical Solutions Group Plc on 22nd July 2026.
The disclosure was made under Rule 8.5 of the Takeover Code, which governs public dealing disclosures by exempt principal traders with recognised intermediary status.
Investec Bank plc submitted the filing in its capacity as an exempt principal trader dealing in a client-serving capacity during the relevant period.
The bank holds a notable advisory relationship with the company, as Investec is serving as Advisor and Joint Broker to Advanced Medical Solutions Group Plc in connection with the offer.
In terms of share activity, Investec purchased a total of 319,244 ordinary shares, with prices ranging from a low of 280p to a high of 280.25p per unit.
On the selling side, the bank disposed of 302,211 ordinary shares, with all sales executed at a price of 280p per unit during the same dealing session.
The volume difference between purchases and sales indicates a modest net acquisition of ordinary shares during the dealing period covered by the disclosure.
No cash-settled derivative transactions, stock-settled derivative transactions, or options activity was reported as part of this regulatory filing.
Investec confirmed there are no indemnity arrangements, option agreements, or understandings relating to voting rights or future acquisition of relevant securities connected to this offer.
The contact named on the disclosure is Priyali Bhattacharjee, reachable by telephone, with the filing dated 23rd July 2026 in accordance with regulatory requirements.
Public disclosures of this nature under Rule 8 of the Takeover Code are required to be made to a Regulatory Information Service to ensure full market transparency.
The Panel’s Market Surveillance Unit remains available for consultation regarding dealing disclosure requirements under the Code for all relevant parties.
